⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5150825 | 0.76 | — | — | |
| SCHEMBL6119518 | 0.72 | KDM4E (0.49) | — | |
| SCHEMBL14967178 | 0.71 | KDM4E (0.43) | — | |
| SCHEMBL11927686 | 0.70 | KDM4E (0.37) | — | |
| SCHEMBL623702 | 0.67 | — | — | |
| SCHEMBL9603284 | 0.66 | MAPT (0.37) | — | |
| SCHEMBL1789380 | 0.66 | MEN1 (0.50) | — | |
| SCHEMBL27854213 | 0.66 | MAOA (0.40) | — | |
| SCHEMBL20252828 | 0.65 | NQO1 (0.33) | — | |
| SCHEMBL14337145 | 0.64 | KDM4E (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534827-B2 | Methods for polymorphic screening | Université de Montréal (CA) | 2026-01-27 | — | — | US | disclosed |
| US-20230075935-A1 | METHODS FOR POLYMORPHIC SCREENING | Université de Montréal (CA) | 2023-03-09 | — | — | US | disclosed |
| US-20230075935-A1 | METHODS FOR POLYMORPHIC SCREENING | Université de Montréal (CA) | 2023-03-09 | — | — | US | disclosed |
| WO-2021146796-A1 | METHODS FOR POLYMORPHIC SCREENING | UNIVERSITE DE MONTREAL (CA) | 2021-07-29 | — | — | WO | disclosed |
| WO-2021146796-A1 | METHODS FOR POLYMORPHIC SCREENING | UNIVERSITE DE MONTREAL (CA) | 2021-07-29 | — | — | WO | disclosed |
| US-20140275041-A1 | OXAZOLE TYROSINE KINASE INHIBITORS | SAREUM LIMITED (GB) | 2014-09-18 | — | — | US | disclosed |